Skip to main content

Advertisement

SpringerLink
Log in

Indolizine: a biologically active moiety

  • Review Article
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

The discovery of camptothecin and its analogs was the major breakthrough through which “Indolizine moiety” came into limelight. Although major part of the research on indolizine derivatives is focused on anticancer drug discovery, these derivatives have also been screened for different biological activities such as antitubercular, antioxidant, antimicrobial, anticancer, and anti-inflammatory activities to name a few. Despite being an important medicinal moiety, a detailed review on the biologically active potential of indolizine derivative is unavailable. To the best of our knowledge, previous reviews on indolizine derivatives mainly focused on their chemistry and synthesis. The present review discusses the versatile nature of indolizine derivatives and their possible mechanism of action. Important SAR points are discussed with each study to highlight the rationale behind the study. Furthermore, the present review also provides information about current/future prospects of the topic and different indolizine derivatives in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Abele E, Abele R, Lukevics E (2003) Pyridine oximes: synthesis, reactions, and biological activity (Review). Chem Heterocycl Compd 39(7):825–865

    Article  CAS  Google Scholar 

  • Abele E, Abele R, Lukevics E (2004) Pyrrole oximes: synthesis, reactions, and biological activity (Review). Chem Heterocycl Compd 40(1):1–15

    Article  CAS  Google Scholar 

  • Baumer W, Hoppmann J, Rundfeldt C, Kietzmann M (2007) Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. Inflamm Allergy Drug Targets 6(1):17–26

    Article  PubMed  Google Scholar 

  • Bloch WM, Derwent-Smith SM, Issa F, Morris JC, Rendina LM, Sumby CJ (2011) Fused pyrazino [2, 3-b] indolizine and indolizino [2, 3-b] quinoxaline derivatives; synthesis, structures, and properties. Tetrahedron 67(48):9368–9375

    Article  CAS  Google Scholar 

  • Burris HA, Rivkin S, Reynolds R, Harris J, Wax A, Gerstein H, Mettinger KL, Staddon A (2005) Phase II trial of oral rubitecan in previously treated pancreatic cancer patients. Oncologist 10(3):183–190

    Article  CAS  PubMed  Google Scholar 

  • Butler MS (2004) The role of natural product chemistry in drug discovery. J Nat Prod 67(12):2141–2153 2004

    Article  CAS  PubMed  Google Scholar 

  • Butler MS (2005) Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 22(2):162–195

    Article  CAS  PubMed  Google Scholar 

  • Butler MS (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 25(3):475–516

    Article  CAS  PubMed  Google Scholar 

  • Chai W, Breitenbucher JG, Kwok A, Li X, Wong V, Carruthers NI, Lovenberg TW, Mazur C, Wilson SJ, Axe FU, Jones TK (2003) Non-imidazole heterocyclic histamine H3 receptor antagonists. Bioorg Med Chem Lett 13(10):1767–1770

    Article  CAS  PubMed  Google Scholar 

  • Chandrashekhar N, Karvekar MD, Das AK (2008) Synthesis and antioxidant activity of 3, 3′-diselanediylbis(N, N-disubstituted indolizine-1-carboxamide):and derivatives. S Afr J Chem 61:53–55

    Google Scholar 

  • Chen S, Xia Z, Nagai M, Lu R, Kostik E, Przewloka T, Song M, Chimmanamada D, James D, Zhang S, Jiang J, Ono M, Koya K, Sun L (2011) Novel indolizine compounds as potent inhibitors of phosphodiesterase IV(PDE4): structure-activity relationship. MedChemComm 2(3):176–180

    Article  CAS  Google Scholar 

  • Cheng Y, An LK, Wu N, Wang XD, Bu XZ, Huang ZS, Gu LQ (2008) Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives. Bioorg Med Chem 16(8):4617–4625

    Article  CAS  PubMed  Google Scholar 

  • Cingolani GM, Claudi F, Venturi F (1988) Indolizine derivatives with biological activity V 1-(2-Aminoethyl)-2-methylindolizine and its N-alkyl derivatives. Eur J Med Chem 23(3):291–294

    Article  CAS  Google Scholar 

  • Cingolani GM, Claudi F, Massi M, Venturi F (1990) Indolizine derivatives with biological activity VI 1-(2-aminoethyl)-3-benzyl-7-methoxy-2-methylindolizine, benanserin structural analogue. Eur J Med Chem 25(8):709–712

    Article  CAS  Google Scholar 

  • Clive DLJ, Yang H, Lewanczuk RZ (2001) Synthesis and in vitro activity of a non-epimerizable analog of the angiotensin-converting enzyme inhibitor A58365A. CR Acad Sci Ser IIc: Chim 4(6):505–512

    CAS  Google Scholar 

  • Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332(24):1589–1593

    Article  CAS  PubMed  Google Scholar 

  • Dallavalle S, Ferrari A, Biasotti B, Merlini L, Penco S, Gallo G, Marzi M, Tinti MO, Martinelli R, Pisano C, Carminati P, Carenini N, Beretta G, Perego P, De Cesare M, Pratesi G, Zunino F (2001) Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity. J Med Chem 44(20):3264–3274

    Article  CAS  PubMed  Google Scholar 

  • Dannhardt G, Meindl W, Gussmann S, Ajili S, Kappe T (1987) Anti-mycobacterial 7-hydroxy-2, 3-dihydro-1H-indolizin-5-ones. Eur J Med Chem 22(6):505–510

    Article  CAS  Google Scholar 

  • Darwish ES (2008) Facile synthesis of heterocycles via 2-picolinium bromide and antimicrobial activities of the products. Molecules 13(5):1066–1078

    Article  CAS  PubMed  Google Scholar 

  • De Cesare M, Pratesi G, Perego P, Carenini N, Tinelli S, Merlini L, Penco S, Pisano C, Bucci F, Vesci L, Pace S, Capocasa F, Carminati P, Zunino F (2001) Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin. Cancer Res 61(19):7189–7195

    PubMed  Google Scholar 

  • Demarquay D, Huchet M, Coulomb H, Lesueur-Ginot L, Lavergne O, Camara J, Kasprzyk PG, Prevost G, Bigg DC (2004) BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo. Cancer Res 64(14):4942–4949

    Article  CAS  PubMed  Google Scholar 

  • Devine MD, Duke SO, Fedtke C (1993) Physiology of herbicide action. Prentice Hall, New Jersey

    Google Scholar 

  • DeVinney R, Steele-Mortimer O, Finlay BB (2000) Phosphatases and kinases delivered to the host cell by bacterial pathogens. Trends Microbiol 8(1):29–33

    Article  CAS  PubMed  Google Scholar 

  • Gundersen LL, Negussie AH, Rise F, Ostby OB (2003) Antimycobacterial activity of 1-substituted indolizines. Arch Pharm Pharm Med Chem 336(3):191–195

    Article  CAS  Google Scholar 

  • Guo W, Miao Z, Sheng C, Yao J, Liu W, Zhu L, Zhang Y, Cheng P, Dong G, Zhuang C, Zhang W (2011) Synthesis of 9-(heteroarylmethylidene)amino derivatives of homocamptothecin with biological activities. Chem Biodivers 8(7):1266–1273

    Article  CAS  PubMed  Google Scholar 

  • Hagishita S, Yamada M, Shirahase K, Okada T, Murakami Y, Ito Y, Matsuura T, Wada M, Kato T, Ueno M, Chikazawa Y, Yamada K, Ono T, Teshirogi I, Ohtani M (1996) Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives. J Med Chem 39(19):3636–3658

    Article  CAS  PubMed  Google Scholar 

  • Harrell WB, Doerge RF (1967) Mannich bases from 2-phenylindolizines I 3-Alkyl-1-dialkylaminomethyl derivatives. J Pharm Sci 56(2):225–228

    Article  CAS  PubMed  Google Scholar 

  • Hazra A, Mondal S, Maity A, Naskar S, Saha P, Paira R, Sahu KB, Paira P, Ghosh S, Sinha C, Samanta A, Banerjee S, Mondal NB (2011) Amberlite-IRA-402(OH):ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products. Eur J Med Chem 46(6):2132–2140

    Article  CAS  PubMed  Google Scholar 

  • Hohenschutz LD, Bell EA, Jewess PJ, Leworthy DP, Pryce RJ, Arnold E, Clardy J (1981) Castanospermine, A 1,6,7,8-tetrahydroxyoctahydroindolizine alkaloid, from seeds of Castanospermum australe. Phytochemistry 20(4):811–814

    Article  CAS  Google Scholar 

  • Hori K, Saito S (2003) Microvascular mechanisms by which the combretastatin A-4 derivative AC7700(AVE8062):induces tumour blood flow stasis. Br J Cancer 89(7):1334–1344

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Houslay MD, Schafer P, Zhang KY (2005) Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10(22):1503–1519

    Article  CAS  PubMed  Google Scholar 

  • Huang Z, Mancini JA (2006) Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD. Curr Med Chem 13(27):3253–3562

    Article  CAS  PubMed  Google Scholar 

  • Hunt AH, Mynderse JS, Samlaska SK, Fukuda DS, Maciak GM, Kirst HA, Occolowitz JL, Swartzendruber JK, Jones ND (1988) Structure elucidation of A58365A and A58365B, angiotensin converting enzyme inhibitors produced by Streptomyces chromofuscus. J Antibiot 41(6):771–779

    Article  CAS  PubMed  Google Scholar 

  • Ipsen (2008) An innovation driven International Specialty Pharma http://www.ipsen.com/wpcontent/uploads/2013/02/20080318. Lehman brothers 10th annual global healthcare conference Miami 11.pdf. Accessed 23 Jan 2014

  • Ipsen (2012) Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC). http://apps.who.int/trialsearch/trial.aspx?trialid=NCT00080015. Accessed 23 Jan 2014

  • Jaisankar P, Pal B, Manna RK, Pradhan PK, Medda S, Basu MK, Giri VS (2003) Synthesis of antileishmanial(5R)-(-)-5-carbomethoxy-3-formyl-5, 6-dihydroindolo-[2, 3-a]-indolizine. ARKIVOC ix:150–157

  • James DA, Koya K, Li H, Liang G, Xia Z, Ying W, Wu Y, Sun L (2008) Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines. Bioorg Med Chem Lett 18(6):1784–1787

    Article  CAS  PubMed  Google Scholar 

  • Jean-Pierre J, Levade T, Thurneyssen O, Chiron M, Bordier C, Michel Attal, Pierre Chatelain, Laurent G (1992) In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction. Cancer Res 52(5):1352–1359

    Google Scholar 

  • Jorgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, Bain S, Naerum L, Wassermann K (2000a) Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine(NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor. Bioorg Med Chem Lett 10(4):399–402

    Article  CAS  PubMed  Google Scholar 

  • Jorgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, Naerum L, Wassermann K (2000b) Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives. Bioorg Med Chem Lett 10(20):2383–2386

    Article  CAS  PubMed  Google Scholar 

  • Kharb R, Bansal K, Sharma AK (2012) A valuable insight into recent advances on antimicrobial activity of piperazine derivatives. Der Pharma Chemica 4(6):2470–2488

    CAS  Google Scholar 

  • Kim ND, Park ES, Kim YH, Moon SK, Lee SS, Ahn SK, Yu DY, No KT, Kim KH (2010) Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents. Bioorg Med Chem 18(19):7092–7100

    Article  CAS  PubMed  Google Scholar 

  • Kim GM, Kim YS, Kang YA, Jeong J-H, Kim SM, Hong YK, Sung JH, Lim ST, Kim JH, Kim SK, Cho BC (2012) Efficacy and toxicity of Belotecan for relapsed or refractory small cell lung cancer patients. J Thorac Oncol 7(4):731–736

    Article  CAS  PubMed  Google Scholar 

  • Koul A, Choidas A, Treder M, Tyagi AK, Drlica K, Singh Y, Ullrich A (2000) Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis. J Bacteriol 182(19):5425–5432

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kumar S, Bawa S, Gupta H (2009) Biological activities of quinoline derivatives Mini-Rev. Med Chem 9(14):1648–1654

    CAS  Google Scholar 

  • Kumari S, Sharma PK, Kumar N (2010) Imidazole and its biological activities: a review. Chem Sin 1:36–47

    Google Scholar 

  • Lagoja IM (2005) Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers 2(1):1–50

    Article  CAS  PubMed  Google Scholar 

  • Lee WS, Kanai Y, Wells RG, Hediger MA (1994) The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression. J Biol Chem 269(16):12032–12039

    CAS  PubMed  Google Scholar 

  • Leurs R, Blandina P, Tedford C, Timmerman H (1998) The histamine H3 receptor; a target for new drugs, 1st edn. Elsevier, Amsterdam, p 177

    Google Scholar 

  • Li H, Xia Z, Chen S, Koya K, Ono M, Sun L (2007) Development of a practical synthesis of STA-5312, a novel indolizine oxalylamide microtubule inhibitor. Org Process Res Dev 11:246–250

    Article  CAS  Google Scholar 

  • Lobo RA (1997) The post menopausal state and estrogen deficiency. In: Lindsay R, Dempster DW Jordan VC Estrogens and Antiestrogen, Lippincott-Raven, Philadelphia, pp 63–72

  • Lv H, Ren J, Ma S, Xu S, Qu J, Liu Z, Zhou Q, Chen X, Yu S (2012) Synthesis, biological evaluation and mechanism studies of deoxytylophorinine and its derivatives as potential anticancer agents. PLoS ONE 7(1):e30342

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mackenzie B, Panayotova-Heiermann M, Loo DD, Lever JE, Wright EM (1994) SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation. J Biol Chem 269(36):22488–22491

    CAS  PubMed  Google Scholar 

  • Mederski W, Beier N, Burgdorf LT, Gericke R, Klein M, Tsaklakidis C (2012) Indolizine derivatives and the use thereof as antidiabetics. US Patent 8,106,067 B2, Jan 31, 2012

  • Miller KJ, Newlin DD (1982) Interactions of molecules with nucleic acids VI Computer design of chromophoric intercalating agents. Biopolymers 21(3):633–652

    Article  CAS  PubMed  Google Scholar 

  • Millet R, Domarkas J, Rigo B, Goossens L, Goossens JF, Houssin R, Henichart JP (2002) Novel potent substance P and neurokinin A receptor antagonists Conception, synthesis and biological evaluation of indolizine derivatives. Bioorg Med Chem 10(9):2905–2912

    Article  CAS  PubMed  Google Scholar 

  • Mishra BB, Tiwari VK (2011) Natural products in drug discovery: Clinical evaluations and investigations. Opportunity Challenge and Scope of Natural Products in Medicinal Chemistry p. 1–61

  • Moore MH, Hunter WN, d’Estaintot BL, Kennard O (1989) DNA-drug interactions The crystal structure of d(CGATCG):complexed with daunomycin. J Mol Biol 206(4):693–705

    Article  CAS  PubMed  Google Scholar 

  • Mynderse JS, Samlaska SK, Fukuda DS, Du Bus RH, Baker PJ (1985) Isolation of A58365A and A58365B, angiotensin converting enzyme inhibitors produced by Streptomyces chromofuscus. J Antibiot 38(8):1003–1007

    Article  CAS  PubMed  Google Scholar 

  • Nasir AI, Gundersen LL, Rise F, Antonsen O, Kristensen T, Langhelle B, Bast A, Custers I, Haenen GR, Wikstrom H (1998) Inhibition of lipid peroxidation mediated by indolizines. Bioorg Med Chem Lett 8(14):1829–1832

    Article  CAS  PubMed  Google Scholar 

  • Nihei Y, Suga Y, Morinaga Y, Ohishi K, Okano A, Ohsumi K, Hatanaka T, Nakagawa R, Tsuji T, Akiyama Y, Saito S, Hori K, Sato Y, Tsuruo T (1999) A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors. Jpn J Cancer Res 90(9):1016–1025

    Article  CAS  PubMed  Google Scholar 

  • Olejnikova P, Birosova L, Svorc L (2009) Antimicrobial and antimutagenic properties of newly synthesized derivatives of indolizine. Sci Pharm 77:216

    Article  Google Scholar 

  • Pandey G, Dumbre SG, Pal S, Khan MI, Shabab M (2007) Synthesis and evaluation of 1-deoxy-8-epi-castanospermine, 1-deoxy-8-hydroxymethyl castanospermine, and(6S,7S,8R,8aR)-8-amino-octahydroindolizine-6,7-diol. Tetrahedron 63(22):4756–4761

    Article  CAS  Google Scholar 

  • Patent Evaluation (1993) Indolizine 5α-reductase inhibitors. Expert Opin Ther Pat 3(5):597–599

    Article  Google Scholar 

  • Pathak D, Sharma G, Sharma V, Aggarwal S (2011) Synthesis and biological evaluation some novel indoles. Ind J Het Chem 20:401–402

    CAS  Google Scholar 

  • Pratesi G, Beretta GL, Zunino F (2004) Gimatecan, a novel camptothecin with a promising preclinical profile. Anticancer Drugs 15(6):545–552

    Article  CAS  PubMed  Google Scholar 

  • Ranga R, Sharma V, Kumar V (2013) New thiazolidinyl analogs containing pyridine ring: synthesis, biological evaluation and QSAR studies. Med Chem Res 22(4):1538–1548

    Article  CAS  Google Scholar 

  • Sharma V, Kumar P, Pathak D (2010) Biological importance of the indole nucleus in recent years: a comprehensive review. J Het Chem 47:491–502

    CAS  Google Scholar 

  • Sharma V, Kumar V, Kumar P (2013) Heterocyclic chalcone analogues as potential anticancer agents. Anticancer Agents Med Chem 13:422–432

    CAS  PubMed  Google Scholar 

  • Shen YM, Lv PC, Chen W, Liu PG, Zhang MZ, Zhu HL (2010) Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line. Eur J Med Chem 45(7):3184–3190

    Article  CAS  PubMed  Google Scholar 

  • Shigemitsu Y, Komiya K, Mizuyama N, Tominaga Y (2008) TD-DFT investigation on the electronic spectra of novel N-methylmaleimides linked with indolizine ring system. THEOCHEM 855(1–3):92–101

    Article  CAS  Google Scholar 

  • Shiose Y, Ochi Y, Kuga H, Yamashita F, Hashida M (2007) Relationship between drug release of DE-310, macromolecular prodrug of DX-8951f, and cathepsins activity in several tumors. Biol Pharm Bull 30(12):2365–2370

    Article  CAS  PubMed  Google Scholar 

  • Siegrist R, Zürcher M, Baumgartner C, Seiler P, Diederich F, Daum S, Fischer G, Klein C, Dangl M, Schwaiger MA (2007) Novel synthesis of highly substituted perhydropyrrolizines, perhydroindolizines, and pyrrolidines: inhibition of the peptidyl-prolyl cis/trans isomerase(PPIase):pin1. Helv Chim Acta 90(2):217–259

    Article  CAS  Google Scholar 

  • Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Jo Corbin C, Mendelson CR (1993) Tissue-specific promoters regulate aromatase cytochrome P450 expression. J Steroid Biochem Mol Biol 44(4):321–330

    Article  CAS  PubMed  Google Scholar 

  • Singh GS, Mmatli EE (2011) Recent progress in synthesis and bioactivity studies of indolizines. Eur J Med Chem 46(11):5237–5257

    Article  CAS  PubMed  Google Scholar 

  • Sinha J, Raay B, Das N, Medda S, Garai S, Mahato SB, Basu MK (2002) Bacopasaponin C: critical evaluation of anti-leishmanial properties in various delivery modes. Drug Deliv 9(1):55–62

    Article  CAS  PubMed  Google Scholar 

  • Sisodiya PS (2013) Plant derived anticancer agents: a review. Int J Res Dev Pharm L Sci 2(2):293–308

    CAS  Google Scholar 

  • Smith SC, Clarke ED, Ridley SM, Bartlett D, Greenhow DT, Glithro H, Klong AY, Mitchell G, Mullier GW (2005) Herbicidal indolizine-5,8-diones: photosystem I redox mediators. Pest Manag Sci 61(1):16–24

    Article  CAS  PubMed  Google Scholar 

  • Sonnet P, Dallemagne P, Guillon J, Enguehard C, Stiebing S, Tanguy J, Bureau R, Rault S, Auvray P, Moslemi S, Sourdaine P, Seralini GE (2000) New aromatase inhibitors synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives. Bioorg Med Chem 8(5):945–955

    Article  CAS  PubMed  Google Scholar 

  • Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA (1995) Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 274(2):137–142

    Article  CAS  PubMed  Google Scholar 

  • Teklu S, Gundersen LL, Larsen T, Malterud KE, Rise F (2005) Indolizine 1-sulfonates as potent inhibitors of 15-lipoxygenase from soybeans. Bioorg Med Chem 13(9):3127–3139

    Article  CAS  PubMed  Google Scholar 

  • Tomlin CDS (2000) The pesticide manual, 12th edn. British Crop Protection Council, Farnham

    Google Scholar 

  • Tomlin, CDS (2002–2003) The e-pesticide manual. Version 22; British Crop Protection Council, Farnham, Surrey

  • Tukulula M, Klein R, Kaye PT (2010) Indolizine studies, part 5: indolizine-2-carboxamides as potential hiv-1 protease inhibitors. Synth Commun 40(13):2018–2028

    Article  CAS  Google Scholar 

  • Unknown (2013) Drugs in clinical development for lung cancer: summary and table. Pharm Med 27(2):95–127

    Article  Google Scholar 

  • Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem 39(1):44–84

    Article  CAS  Google Scholar 

  • Vaught JL, Raffa RB (1991) Centrally-mediated antinociceptive action of RWJ-22757 (formerly McN-5195): involvement of spinal descending inhibitory pathways (a hypothesis). Life Sci 48(23):2233–2241

    Article  CAS  PubMed  Google Scholar 

  • Vaught JL, Carson JR, Carmosin RJ, Blum PS, Persico FJ, Hageman WE, Shank RP, Raffa RB (1990) Antinociceptive action of McN-5195 in rodents: a structurally novel (indolizine) analgesic with a nonopioid mechanism of action. J Pharmacol Exp Ther 255(1):1–10

    CAS  PubMed  Google Scholar 

  • Vemula V, Vurukonda S, Bairi C (2011) Indolizine derivatives: recent advances and potential pharmacological activities Int J Pharm Sci Rev Res 11:159–163

    CAS  Google Scholar 

  • Wadsworth DH, Bender SL, Smith DL, Luss HR, Weidner CH (1986) Indolizines 2 Preparation of 1- and 3-indolizinols and their esters. J Org Chem 51(24):4639–4644

    Article  CAS  Google Scholar 

  • Wadsworth DH, Weidner CH, Bender SL, Nuttall RH, Luss HR (1989) Indolizines 3 Oxidation products of indolizinols: radicals, ions, and oxidized dimers. J Org Chem 54(15):3652–3660

    Article  CAS  Google Scholar 

  • Wall ME, Wani MC, Cook CE, Palmer KH, McPhail HT, Sim GA (1966) Plant antitumor agents 1 The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminate. J Am Chem Soc 88:3888–3890

    Article  CAS  Google Scholar 

  • Weide T, Arve L, Prinz H, Waldmann H, Kessler H (2006) 3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors. Bioorg Med Chem Lett 16(1):59–63

    Article  CAS  PubMed  Google Scholar 

  • Weidner CH, Wadsworth DH, Bender SL, Beltman DJ (1989) Indolizines 4 dyes derived from oxoindolizinium ions and active methylene compounds. J Org Chem 54(15):3660–3664

    Article  CAS  Google Scholar 

  • Weidner CH, Michaels FM, Beltman DJ, Montgomery CJ, Wadsworth DH, Briggs BT, Picone ML (1991) Indolizines 5 preparation and structural assignments of azaindolizinols. J Org Chem 56(19):5594–5598

    Article  CAS  Google Scholar 

  • Wu N, Wu XW, Agama K, Pommier Y, Du J, Li D, Gu LQ, Huang ZS, An LK (2010) A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells. Biochemistry 49(47):10131–10136

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Yokota Y, Hanasaki K, Ono T, Nakazato H, Kobayashi T, Arita H (1999) Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms. Biochim Biophys Acta 1438(2):213–222

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y (2005) Magic bullets and tuberculosis drug targets. Annu Rev Pharmacool Toxicol 45:529–564

    Article  CAS  Google Scholar 

  • Zhang KY, Ibrahim PN, Gillette S, Bollag G (2005) Phosphodiesterase-4 as a potential drug target. Expert Opin Ther Targets 9(6):1283–1305

    Article  CAS  PubMed  Google Scholar 

  • Zhu L, Zhang X, Lei N, Liu W, Miao Z, Zhuang C, Sheng C, Guo W, Dong G, Yao J, Cheng P, Zhang W (2012) Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibitors. Chem Biodivers 9(6):1084–1094

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Mr. Vikas Sharma is thankful to All India Council for Technical Education, India for providing the National Doctoral Fellowship for PhD research work vide letter no. F.No. 14/AICTE/RIFD/NDF(Policy-I)/01/2012-13.

Conflict of interest

The authors declare that they have no conflicts of interest.

Author information

Author notes

  1. Vipin Kumar

    Present address: Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Ajmer, 305801, Rajasthan, India

Authors and Affiliations

  1. Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, 136119, Haryana, India

    Vikas Sharma & Vipin Kumar

Authors
  1. Vikas Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vipin Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vipin Kumar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, V., Kumar, V. Indolizine: a biologically active moiety. Med Chem Res 23, 3593–3606 (2014). https://doi.org/10.1007/s00044-014-0940-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-014-0940-1

Keywords

Search

Navigation